Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-25Clinical Trial Results: Nirogacestat in Ovarian Granulosa Cell Tumors [Phase 2]
Phase 2 clinical trial results for nirogacestat in ovarian granulosa cell tumors have been completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Results: Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer [Phase 2]
Phase 2 trial results for elenagen plasmid in combination with gemcitabine show efficacy in platinum-resistant ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Results: Michigan Genetic Hereditary Testing (MiGHT) [NA]
Results from the MiGHT genetic hereditary testing trial conducted at University of Michigan Rogel Cancer Center in breast, colorectal, and o…
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating NC410 plus pembrolizumab in advanced/metastatic solid tumors with various MSI statuses; terminated with posted re…
-
CLINICAL_TRIALS trial_result · 2026-08-05Clinical Trial Results: Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial assessing durvalumab and tremelimumab in recurrent or refractory ovarian, primary peritoneal, or fallopian tube cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-08-05Clinical Trial Results: Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod [Phase 2]
Phase 2 trial evaluating dendritic cell/tumor fusions with GM-CSF and Imiquimod in ovarian cancer and related peritoneal cancers; study term…
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Results: ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK [Phase 1, Phase 2]
Phase 1/2 trial evaluating FAK kinase inhibitor to re-sensitize carboplatin-resistant ovarian cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-13Clinical Trial Results: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
Phase 1/2 trial results for TC-510 in advanced mesothelin-expressing cancers were terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Results: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of pegylated IL-10 (pegilodecakin) in adults with advanced solid tumors; results from a first-in-human trial assessing safety …
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating CRLX101 (NLG207) with weekly paclitaxel in recurrent/persistent epithelial ovarian, Fallopian tube, or primary pe…
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Results: Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial results for Olvi-Vec oncolytic immunotherapy in recurrent or refractory ovarian cancer show completed study with posted resu…
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients [Phase 3]
Phase 3 clinical trial evaluating durvalumab with chemotherapy and bevacizumab followed by maintenance durvalumab, bevacizumab, and olaparib…
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected [Phase 3]
Phase 3 trial evaluating alpelisib plus olaparib in platinum-resistant/refractory high-grade serous ovarian cancer without germline BRCA mut…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Results: Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation [Phase 2]
Phase 2 trial evaluating bevacizumab and/or niraparib in patients with recurrent endometrial or ovarian cancer harboring ARID1A mutation; st…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 3]
A Phase 3 trial evaluating mirvetuximab soravtansine with bevacizumab versus bevacizumab alone as maintenance therapy in platinum-sensitive …
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Results: A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer [Phase 2]
Phase 2 trial results of a precision medicine approach (SMMART-ACT) in patients with advanced sarcoma, breast, ovarian, pancreatic, or prost…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
A completed clinical trial evaluating risk-reducing removal of the ovaries/fallopian tubes and CA-125 screening to lower ovarian cancer risk…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass
The completed trial evaluated the diagnostic utility of culdocentesis in patients with a suspicious adnexal mass. The study relates to ovari…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis [Phase 1]
Phase 1 study of Radspherin in recurrent ovarian cancer with peritoneal carcinomatosis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers [Phase 2]
Phase 2 trial of AUR 109 in ovarian cancer, colorectal cancer, and renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Evaluating Cascade Communication Methods
A completed University of Pennsylvania clinical trial evaluating cascade communication methods for individuals with BRCA1 or BRCA2 mutations…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging [Phase 1]
Phase 1 clinical trial evaluating metabolic imaging to assess the aggressiveness of ovarian cancer. The study status is suspended.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression [Phase 2]
Phase 2 study of INCB123667 for platinum‑resistant ovarian cancer with Cyclin E1 overexpression is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Elements of Adaptive Immunity in Epithelial Ovarian Cancer
A completed clinical trial update examining elements of adaptive immunity in epithelial ovarian cancer, specifically the high-grade serous s…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: GEN1047 for Solid Tumors - First in Human (FIH) Trial [Phase 1, Phase 2]
Genmab's GEN1047 first-in-human Phase 1/2 trial in solid tumors has been terminated, with indications including breast cancer, endometrial c…